Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H30O3 |
Molecular Weight | 342.4718 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])C=C(C)C4=CC(=O)CC[C@]34C
InChI
InChIKey=VXIMPSPISRVBPZ-NWUMPJBXSA-N
InChI=1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1
Molecular Formula | C22H30O3 |
Molecular Weight | 342.4718 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:15 UTC 2023
by
admin
on
Fri Dec 15 14:58:15 UTC 2023
|
Record UNII |
EA6LD1M70M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG03AC05
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03AC05
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
LIVERTOX |
593
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03FB04
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
CFR |
21 CFR 520.1341
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
NCI_THESAURUS |
C776
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QG03DB02
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03FA08
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
L02AB01
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QG03FA08
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03AB01
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QG03AB01
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
NDF-RT |
N0000175602
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03DB02
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QL02AB01
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
NDF-RT |
N0000011301
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QG03FB04
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-ATC |
G03AA04
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
||
|
WHO-VATC |
QG03AA04
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
EA6LD1M70M
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
1529
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
C630
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
6722
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
6703
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
3233
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
EA6LD1M70M
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201139
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
MEGESTROL
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
3562-63-8
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
SUB08712MIG
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
19090
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
DTXSID00100933
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
222-628-6
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
100000081461
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY | |||
|
D008535
Created by
admin on Fri Dec 15 14:58:15 UTC 2023 , Edited by admin on Fri Dec 15 14:58:15 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||